Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001179110-21-006888

Options or other derivatives

  • Director acquired 12,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
CONRAD HERBERT J Director 2021-06-17 Grant or award · Non-Qualified Stock Option (right to buy) +12,000 12,000 D
Loading xslF345X03/edgar.xml…